Brookfield Asset Management Inc. Axonics, Inc. Transaction History

Brookfield Asset Management Inc.

  • $14 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$57.96 - $78.12 $1.41 Million - $1.9 Million
-24,258 Reduced 62.79%
14,373 $1.01 Million
Q2 2022

Nov 16, 2022
BUY
$39.5 - $64.42 $958,191 - $1.56 Million
24,258 Added 168.77%
38,631 $2.19 Million
Q2 2022

Aug 15, 2022
BUY
$39.5 - $64.42 $1.53 Million - $2.49 Million
38,631 New
38,631 $2.19 Million

Others Institutions Holding AXNX

# of Institutions
188
Shares Held
41.3M
Call Options Held
83.4K
Put Options Held
65.3K
View Full List

About Axonics, Inc.

AXNX Quotes by TradingView
  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email